These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24054820)

  • 1. Quality assurance mechanisms for the unregulated research environment.
    Riedl DH; Dunn MK
    Trends Biotechnol; 2013 Oct; 31(10):552-4. PubMed ID: 24054820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biotech firms look for virtual success.
    Schmidt C
    Cancer Discov; 2012 Jan; 2(1):OF5. PubMed ID: 22585175
    [No Abstract]   [Full Text] [Related]  

  • 3. Current practices in endotoxin and pyrogen testing in biotechnology. The Quality Assurance/Quality Control Task Group. Parenteral Drug Association.
    J Parenter Sci Technol; 1990; 44(1):39-45. PubMed ID: 2313492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The places to be.
    Smaglik P
    Nature; 2005 Feb; 433(7025):551. PubMed ID: 15690047
    [No Abstract]   [Full Text] [Related]  

  • 5. [Problems with Laboratory Notebooks in Academia and How to Resolve Them].
    Kakuta H
    Yakugaku Zasshi; 2019; 139(6):887-890. PubMed ID: 31155531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Process analytical technology (PAT) for biopharmaceutical products.
    Rathore AS; Bhambure R; Ghare V
    Anal Bioanal Chem; 2010 Sep; 398(1):137-54. PubMed ID: 20480150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating standard operating procedures and industry notebook standards to evaluate students in laboratory courses.
    Wallert MA; Provost JJ
    Biochem Mol Biol Educ; 2014; 42(1):41-9. PubMed ID: 24376028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-process testing and limits.
    Sjöholm I
    Dev Biol Stand; 1997; 91():73-8. PubMed ID: 9413685
    [No Abstract]   [Full Text] [Related]  

  • 9. Industry is more alarmed about reproducibility than academia.
    Bespalov A; Barnett AG; Begley CG
    Nature; 2018 Nov; 563(7733):626. PubMed ID: 30487623
    [No Abstract]   [Full Text] [Related]  

  • 10. Innovation and compliance are not diametrically opposed.
    Raab GK
    Qual Assur; 1994 Mar; 3(1):2-8. PubMed ID: 7804614
    [No Abstract]   [Full Text] [Related]  

  • 11. Companies balk at California's patent rules for stem cell research.
    Keim B
    Nat Med; 2007 Jan; 13(1):6. PubMed ID: 17206112
    [No Abstract]   [Full Text] [Related]  

  • 12. Development of specifications for biotechnology products--perspective from Europe.
    Trouvin JH
    Dev Biol Stand; 1997; 91():25-30. PubMed ID: 9413679
    [No Abstract]   [Full Text] [Related]  

  • 13. Guidelines and policies for medical writers in the biotech industry: an update on the controversy.
    Foote M
    Biotechnol Annu Rev; 2004; 10():259-64. PubMed ID: 15504710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global perspective on specifications for biotechnology products--perspective from Japan.
    Hayakawa T
    Dev Biol Stand; 1997; 91():15-23. PubMed ID: 9413678
    [No Abstract]   [Full Text] [Related]  

  • 15. Process validation for manufacturing of biologics and biotechnology products. Proceedings of a meeting. September 6-7, 2001. Berlin, Germany.
    Dev Biol (Basel); 2003; 113():3-120. PubMed ID: 15116735
    [No Abstract]   [Full Text] [Related]  

  • 16. Hybrid modeling for quality by design and PAT-benefits and challenges of applications in biopharmaceutical industry.
    von Stosch M; Davy S; Francois K; Galvanauskas V; Hamelink JM; Luebbert A; Mayer M; Oliveira R; O'Kennedy R; Rice P; Glassey J
    Biotechnol J; 2014 Jun; 9(6):719-26. PubMed ID: 24806479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality assurance in gastroenterology: QA in research, and research in QA.
    Hoff G
    Best Pract Res Clin Gastroenterol; 2011 Jun; 25(3):427-34. PubMed ID: 21764010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Canadian perspectives on expectations for process validation.
    Ridgway A
    Dev Biol (Basel); 2003; 113():3-8. PubMed ID: 14620846
    [No Abstract]   [Full Text] [Related]  

  • 19. Specifications from a biotechnology industry perspective.
    Garnick RL
    Dev Biol Stand; 1997; 91():31-6. PubMed ID: 9413680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Razing the tollbooths. A call for restricting patents on basic biomedical research.
    Stix G
    Sci Am; 2003 Apr; 288(4):37. PubMed ID: 12661312
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.